ConductScience.org, home

Paper24326467

Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum.

Wang W and 7 others. Parasitol Res, 2014. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum. Papers, record 24326467. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24326467

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum.
PubMed
Journal
Parasitol Res
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.49
iCite
Revised in PubMed
2021-10-21
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang WWei
2Li TYTian-Yu
3Ji YYuan
4Qu GLGuo-Li
5Qian YLYi-Li
6Li HJHong-Jun
7Dai JRJian-Rong
8Liang YSYou-Sheng

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ArtemisininsMajor topic
Schistosoma japonicumMajor topic
Schistosomiasis japonicaMajor topic
SchistosomicidesMajor topic
Administration, Oral
Animals
Artemether
Artesunate
Disease Models, Animal
Drug Resistance
Female
Mice
Mice, Inbred ICR
Praziquantel

Source PubMed

Download CSV of topics

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19207389Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low.J Infect Dis1997https://conductscience.org/library/papers/9207389PubMed
218978535Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.Curr Opin Infect Dis2008https://conductscience.org/library/papers/18978535PubMed
312020890Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia.Acta Trop2002https://conductscience.org/library/papers/12020890PubMed
419793080China's new strategy to block Schistosoma japonicum transmission: experiences and impact beyond schistosomiasis.Trop Med Int Health2009https://conductscience.org/library/papers/19793080PubMed
516125655The public health significance and control of schistosomiasis in China--then and now.Acta Trop2005https://conductscience.org/library/papers/16125655PubMed
611730781The potential of artemether for the control of schistosomiasis.Int J Parasitol2001https://conductscience.org/library/papers/11730781PubMed
716125656Control of schistosomiasis in China.Acta Trop2005https://conductscience.org/library/papers/16125656PubMed
821989013The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine.Nat Med2011https://conductscience.org/library/papers/21989013PubMed
916790382Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk.Lancet Infect Dis2006https://conductscience.org/library/papers/16790382PubMed
1015275183Schistosome resistance to praziquantel: Fact or artifact?Parasitol Today1996https://conductscience.org/library/papers/15275183PubMed
118556789[Field studies on preventive effect of artemether against infection with Schistosoma japonicum].Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi1995https://conductscience.org/library/papers/8556789PubMed
1218930529Schistosomiasis control: experiences and lessons from China.Lancet2008https://conductscience.org/library/papers/18930529PubMed
137625534Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni.Am J Trop Med Hyg1995https://conductscience.org/library/papers/7625534PubMed
1423206326Factors impacting on progress towards elimination of transmission of schistosomiasis japonica in China.Parasit Vectors2012https://conductscience.org/library/papers/23206326PubMed
1512426618Achievements of schistosomiasis control in China.Mem Inst Oswaldo Cruz2002https://conductscience.org/library/papers/12426618PubMed
1618028731Effects of the praziquantel-based control of schistosomiasis japonica in China.Ann Trop Med Parasitol2007https://conductscience.org/library/papers/18028731PubMed
1718257989Epidemiology of schistosomiasis in the People's Republic of China, 2004.Emerg Infect Dis2007https://conductscience.org/library/papers/18257989PubMed
189275368Studies on prophylactic effect of artesunate on schistosomiasis japonica.Chin Med J (Engl)1996https://conductscience.org/library/papers/9275368PubMed
1923358736Application of praziquantel in schistosomiasis japonica control strategies in China.Parasitol Res2013https://conductscience.org/library/papers/23358736PubMed
2011555438Susceptibility of Schistosoma japonicum to praziquantel in China.Trop Med Int Health2001https://conductscience.org/library/papers/11555438PubMed

See all 67 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42278328Plant-Derived Terpenes as Emerging Therapeutics Against Schistosomiasis.Int J Mol Sci2026https://conductscience.org/library/papers/42278328PubMed
37978995Efficacy of artemether against toxocariasis in mice: parasitological and immunopathological changes in brain, liver, and lung.Pathog Glob Health2024https://conductscience.org/library/papers/37978995PubMed
33808016Application of Dendrimers for Treating Parasitic Diseases.Pharmaceutics2021https://conductscience.org/library/papers/33808016PubMed
32048169Research Progress on Artemisinin and Its Derivatives against Hematological Malignancies.Chin J Integr Med2020https://conductscience.org/library/papers/32048169PubMed
27636542Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.PLoS Negl Trop Dis2016https://conductscience.org/library/papers/27636542PubMed
25625682Natural products as leads in schistosome drug discovery.Molecules2015https://conductscience.org/library/papers/25625682PubMed
25244286New uses for old drugs: the tale of artemisinin derivatives in the elimination of schistosomiasis japonica in China.Molecules2014https://conductscience.org/library/papers/25244286PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24326467

GET https://conductscience.org/api/papers/v1/24326467/references?page=2